Analysis | Metabolite Name | Measured Value | Units | Genotype | Intestinal Segment |
---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 2977 | Peak area | FLOX | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 3144 | Peak area | FLOX | Duodenum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 3429 | Peak area | FLOX | Jejunum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 5242 | Peak area | Knockout | Duodenum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 5518 | Peak area | Knockout | Jejunum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 5705 | Peak area | Knockout | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 5930 | Peak area | Knockout | Jejunum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 7565 | Peak area | Knockout | Jejunum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 8083 | Peak area | FLOX | Jejunum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 10025 | Peak area | FLOX | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 10048 | Peak area | FLOX | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 11846 | Peak area | Knockout | Duodenum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 11878 | Peak area | Knockout | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 14598 | Peak area | Knockout | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 14739 | Peak area | FLOX | Duodenum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 14856 | Peak area | FLOX | Duodenum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 19661 | Peak area | FLOX | Jejunum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 20168 | Peak area | Knockout | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 20437 | Peak area | FLOX | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 20455 | Peak area | Knockout | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 25891 | Peak area | Knockout | Duodenum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 26781 | Peak area | Knockout | Jejunum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 32626 | Peak area | FLOX | Jejunum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 41071 | Peak area | FLOX | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 46919 | Peak area | Knockout | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 49391 | Peak area | Knockout | Jejunum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 55014 | Peak area | Knockout | Duodenum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 56312 | Peak area | Knockout | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 61492 | Peak area | Knockout | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 99940 | Peak area | Knockout | Jejunum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 154860 | Peak area | FLOX | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 155829 | Peak area | FLOX | Duodenum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 170417 | Peak area | Knockout | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 170871 | Peak area | FLOX | Duodenum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 175105 | Peak area | Knockout | Duodenum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 180476 | Peak area | FLOX | Duodenum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 186577 | Peak area | Knockout | Duodenum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 217862 | Peak area | FLOX | Jejunum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 226437 | Peak area | FLOX | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 236286 | Peak area | FLOX | Illeum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 344395 | Peak area | Knockout | Jejunum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 412292 | Peak area | FLOX | Jejunum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 475968 | Peak area | FLOX | Jejunum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 553639 | Peak area | Knockout | Duodenum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 838021 | Peak area | FLOX | Duodenum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 892367 | Peak area | Knockout | Duodenum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 955149 | Peak area | FLOX | Duodenum |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | Peak area | FLOX | Jejunum | |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | Peak area | Knockout | Duodenum | |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | Peak area | Knockout | Jejunum |